Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 443-449
Open Access | Times Cited: 1107

Showing 1-25 of 1107 citing articles:

Characteristics of SARS-CoV-2 and COVID-19
Ben Hu, Hua Guo, Peng Zhou, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 141-154
Open Access | Times Cited: 4749
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
Science (2021) Vol. 371, Iss. 6529
Open Access | Times Cited: 2727
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S. Nair, Lihong Liu, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 130-135
Open Access | Times Cited: 2239
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr, Allison J. Greaney, Sarah K. Hilton, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1295-1310.e20
Open Access | Times Cited: 2000
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 657-663
Open Access | Times Cited: 1734
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, et al.
Nature (2020) Vol. 588, Iss. 7839, pp. 682-687
Open Access | Times Cited: 1659
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 639-644
Open Access | Times Cited: 1584
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas, Nell Saunders, Piet Maes, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 671-675
Open Access | Times Cited: 1445
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Nature (2021) Vol. 592, Iss. 7855, pp. 616-622
Open Access | Times Cited: 1438
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 1415
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 676-681
Open Access | Times Cited: 1255
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1212
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 593-602
Open Access | Times Cited: 1195
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan, Jingyou Yu, Noe B. Mercado, et al.
Nature (2020) Vol. 590, Iss. 7847, pp. 630-634
Open Access | Times Cited: 1142
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 664-670
Open Access | Times Cited: 1106
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe (2020) Vol. 29, Iss. 1, pp. 44-57.e9
Open Access | Times Cited: 1062
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen, Xianwen Zhang, James Brett Case, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 717-726
Open Access | Times Cited: 970
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2332-2347.e16
Open Access | Times Cited: 936
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, et al.
ACS Central Science (2020) Vol. 6, Iss. 10, pp. 1722-1734
Open Access | Times Cited: 930
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 477-488.e4
Open Access | Times Cited: 809
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani, Lihong Liu, Yicheng Guo, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 553-556
Open Access | Times Cited: 786
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
Cell (2022) Vol. 186, Iss. 2, pp. 279-286.e8
Open Access | Times Cited: 743
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
Stephany Beyerstedt, Expedito Barbosa Casaro, Érika Bevilaqua Rangel
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 5, pp. 905-919
Open Access | Times Cited: 716
Page 1 - Next Page

Scroll to top